한글목차

학습 장애 치료 시장 규모는 2025년 323억 1,000만 달러에서 2026-2034년에 CAGR 6.93%로 성장하며, 2034년에는 590억 6,000만 달러에 달할 것으로 예측되고 있습니다.

학습장애 치료 시장은 학습장애에 대한 인식이 높아지고 효과적인 중재 전략에 대한 수요가 증가함에 따라 큰 폭의 성장이 예상됩니다. 난독증(읽기장애), ADHD(주의력결핍 및 과잉행동장애), 자폐 스펙트럼 장애 등의 질환에 대한 이해가 깊어짐에 따라 전문적인 교육 자원과 치료적 개입의 필요성이 급증하고 있습니다. 이 시장은 행동치료, 교육 프로그램, 지원 기술 등 다양한 치료 옵션을 포괄하고 있으며, 이러한 분야의 혁신이 개입의 효과를 높이고 있습니다.

또한 포용적 교육에 대한 관심이 높아지면서 학습장애 치료 시장에도 영향을 미치고 있습니다. 교육기관이 다양한 학습 요구에 부응하기 위해 노력하면서 학습장애 학생을 지원하는 개별화 프로그램과 리소스에 대한 수요가 증가하고 있습니다. 이러한 추세에 따라 교육자와 치료사가 협력하여 영향을 받는 개인의 학업적 성공과 사회적 통합을 촉진하기 위한 종합적인 전략이 개발되고 있습니다.

또한 학습장애 분야의 연구개발에 대한 관심이 높아지면서 치료 방법의 혁신이 촉진되고 있습니다. 교육 기관, 의료 서비스 프로바이더, 기술 개발자 간의 협력은 평가 툴와 중재 전략의 발전을 촉진하고 새로운 제품이 학생과 교육자의 진화하는 요구에 부응할 수 있도록 보장합니다. 학습장애인의 성과 향상에 있으며, 조기 진단과 개입의 중요성에 대한 인식이 높아진 것도 시장 성장에 기여하고 있습니다. 요약하면, 학습장애 치료 시장은 기술 발전, 포용적 교육에 대한 관심, 영향을 받는 개인의 삶의 질 향상에 대한 노력으로 인해 견고한 성장이 예상됩니다.

목차

제1장 서론

제2장 개요

제3장 시장 변수, 동향, 프레임워크

제4장 세계의 학습 장애 치료 시장 : 요법별

제5장 세계의 학습 장애 치료 시장 : 적응증별

제6장 세계의 학습 장애 치료 시장 : 최종사용자별

제7장 세계의 학습 장애 치료 시장 : 지역별

제8장 경쟁 구도

제9장 기업 개요

영문목차

The Learning Disabilities Treatment Market size is expected to reach USD 59.06 Billion in 2034 from USD 32.31 Billion (2025) growing at a CAGR of 6.93% during 2026-2034.

The learning disabilities treatment market is poised for significant growth, driven by the increasing recognition of learning disabilities and the rising demand for effective intervention strategies. As awareness of conditions such as dyslexia, ADHD, and autism spectrum disorders grows, the need for specialized educational resources and therapeutic interventions is surging. The market encompasses a range of treatment options, including behavioral therapies, educational programs, and assistive technologies, with innovations in these areas enhancing the effectiveness of interventions.

Moreover, the growing emphasis on inclusive education is influencing the learning disabilities treatment market. As educational institutions strive to accommodate diverse learning needs, there is a rising demand for tailored programs and resources that support students with learning disabilities. This trend is prompting educators and therapists to collaborate in developing comprehensive strategies that promote academic success and social integration for affected individuals.

Furthermore, the increasing focus on research and development in the field of learning disabilities is fostering innovation in treatment methodologies. Collaborations between educational institutions, healthcare providers, and technology developers are driving advancements in assessment tools and intervention strategies, ensuring that new products meet the evolving needs of students and educators. The growing awareness of the importance of early diagnosis and intervention in improving outcomes for individuals with learning disabilities is also contributing to market growth. In summary, the learning disabilities treatment market is set for robust growth, characterized by technological advancements, a focus on inclusive education, and a commitment to enhancing the quality of life for affected individuals.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Therapy

• Stimulant Medication
• Non-Stimulant Medication
• Occupational Therapy
• Complimentary Therapy
• Others

By Indication

• Dyslexia
• Dyspraxia
• Attention Deficit Hyperactivity Disorder (ADHD)
• Others

By End-User

• Hospitals
• Clinic
• Others

COMPANIES PROFILED

• Johnson Johnson, Pfizer Inc, Novartis AG, GlaxoSmithKline plc, Shire, Teva Pharmaceutical Industries Ltd, Eli Lilly and Company, Allergan Inc, Bausch Health Companies Inc, Merck Co Inc, Biogen Inc, F HoffmannLa Roche AG, AbbVie Inc, Takeda Pharmaceutical Co Ltd, Sanofi SA

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL LEARNING DISABILITIES TREATMENT MARKET: BY THERAPY 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Therapy
• 4.2. Stimulant Medication Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Non-Stimulant Medication Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Occupational Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Complimentary Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL LEARNING DISABILITIES TREATMENT MARKET: BY INDICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Indication
• 5.2. Dyslexia Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Dyspraxia Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Attention Deficit Hyperactivity Disorder (ADHD) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL LEARNING DISABILITIES TREATMENT MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Clinic Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL LEARNING DISABILITIES TREATMENT MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Therapy
  • 7.2.2 By Indication
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Therapy
  • 7.3.2 By Indication
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Therapy
  • 7.4.2 By Indication
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Therapy
  • 7.5.2 By Indication
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Therapy
  • 7.6.2 By Indication
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL LEARNING DISABILITIES TREATMENT INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Johnson & Johnson
  • 9.2.2 Pfizer Inc
  • 9.2.3 Novartis AG
  • 9.2.4 GlaxoSmithKline Plc
  • 9.2.5 Shire
  • 9.2.6 Teva Pharmaceutical Industries Ltd
  • 9.2.7 Eli Lilly And Company
  • 9.2.8 Allergan Inc
  • 9.2.9 Bausch Health Companies Inc
  • 9.2.10 Merck & Co. Inc
  • 9.2.11 Biogen Inc
  • 9.2.12 F. Hoffmann-La Roche AG
  • 9.2.13 AbbVie Inc
  • 9.2.14 Takeda Pharmaceutical Co. Ltd
  • 9.2.15 Sanofi S.A